| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-5,544.5340 | -6,257.4770 | -8,719.3910 | -8,534.1710 | -7,338.5050 |
|
Research and Development Expenses
|
-2,124.5020 | -1,834.5060 | -5,403.8360 | -6,043.5970 | -4,754.2710 |
|
Operating Income/Expenses
|
-7,669.0360 | -8,091.9830 | -14,123.2270 | -14,577.7680 | -12,092.7760 |
|
Total Operating Profit/Loss
|
-7,669.0360 | -8,091.9830 | -14,123.2270 | -14,577.7680 | -12,092.7760 |
| Total Net Finance Income/Expense
|
162.8150 | 125.4450 | 20.1240 | -- | -- |
| Irregular Income/Expenses
|
-- | -- | -- | -- | 0 |
|
Non-Operating Income/Expenses, Total
|
162.8150 | 125.4450 | 20.1240 | -- | 0 |
|
Pretax Income
|
-7,506.2210 | -7,966.5380 | -14,103.1030 | -14,577.7680 | -12,092.7760 |
|
Net Income from Continuing Operations
|
-7,506.2210 | -7,966.5380 | -14,103.1030 | -14,577.7680 | -12,092.7760 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-7,506.2210 | -7,966.5380 | -14,103.1030 | -14,577.7680 | -12,092.7760 |
|
Net Income after Non-Controlling/Minority Interests
|
-7,506.2210 | -7,966.5380 | -14,103.1030 | -14,577.7680 | -12,092.7760 |
|
Net Income Available to Common Stockholders
|
-7,506.2210 | -7,966.5380 | -14,103.1030 | -14,577.7680 | -12,092.7760 |
|
Diluted Net Income Available to Common Stockholders
|
-7,506.2210 | -7,966.5380 | -14,103.1030 | -14,577.7680 | -12,092.7760 |
| Basic EPS
|
-2.67 | -5.32 | -17.45 | -23.00 | -22.40 |
| Diluted EPS
|
-2.67 | -5.32 | -17.45 | -23.00 | -22.40 |
|
Basic Weighted Average Shares Outstanding
|
2,697.1050 | 1,498.7930 | 808.1680 | 633.5790 | 540.8210 |
|
Diluted Weighted Average Shares Outstanding
|
2,697.1050 | 1,498.7930 | 808.1680 | 633.5790 | 540.8210 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-7,669.0360 | -8,091.9830 | -14,123.2270 | -14,577.7680 | -12,092.7760 |
|
EBITDA
|
-7,669.0360 | -8,091.9830 | -14,123.2270 | -14,577.7680 | -12,092.7760 |
|
Normalized EBITDA
|
-6,352.5670 | -6,522.2630 | -10,687.6440 | -10,811.6580 | -8,790.4150 |
|
Normalized Income
|
-6,189.7520 | -6,396.8180 | -10,667.5200 | -10,811.6580 | -8,790.4150 |
|
Total Unusual Items
|
1,316.4690 | 1,569.7200 | 3,435.5830 | 3,766.1100 | 3,302.3610 |
|
Total Unusual Items Excluding Goodwill
|
1,316.4690 | 1,569.7200 | 3,435.5830 | 3,766.1100 | 3,302.3610 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 6/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade